MATRIXLABS

Members of the Exchange are hereby informed that the trading in the equity shares of Matrix Laboratories Limited shall be suspended w.e.f. August 14, 2009 (i.e. w.e.f. closing hours of trading on August 13, 2009) on account of voluntary delisting pursuant to the SEBI (Delisting of Securities) Guidelines, 2003. The admission to dealings in securities of the said company shall be withdrawn (delisted) w.e.f. August 21, 2009.

Matrix Laboratories Limited has, with reference to the Delisting of the equity shares of the Company from the Exchange, submitted to the Exchange the details of the name, address and contact numbers of the Contact Person at RTA and at the Company for solving Investor queries post Delisting. The details of the same are as follows: 1) Company:- Name: V. Sheela; Designation: Company Secretary & General Manager (Legal); Address: 1-1-151/1, IV Floor, Sairam Towers, Alexander Road, Secunderabad - 500003; Phone: 91 40 27700363, 30496666; Fax: 91 40 27700343; Email: sheela.vadavalli@matrixlabsindia.co

Citigroup Global Markets India Private Limited has informed the Exchange regarding a public announcement ("Public Announcement") being issued by MP Laboratories (Mauritius) Ltd (hereinafter referred to as the "Acquirer") to the public shareholders of Matrix Laboratories Limited ("Company") in respect of the proposed acquisition of the Offer Shares (as hereinafter defined) and consequent delisting of the fully paid-up equity shares of the Company with a face value of Rs.2 each ("Equity Shares") in accordance with the Securities and Exchange Board of India (Delisting of Securities) Guidelines, 2

Matrix Laboratories Limited has informed the Exchange that pursuant to a resolution passed by the board of directors of the Company dated March 27, 2009, the board of directors have: (1) taken on record the proposal received from MP Laboratories (Mauritius) Ltd dated March 26, 2009, to initiate a voluntary delisting offer to the public shareholders of the Company to delist the shares of the Company from the Bombay Stock Exchange Limited and National Stock Exchange of India Limited; (2) decided that the above matter will be placed before the shareholders for consideration and consent at the ext

Matrix Laboratories Limited has informed the Exchange that "The Board of Directors of Matrix Laboratories Limited ("Company") has received a letter dated March 26, 2009 from MP Laboratories (Mauritius) Ltd ("MP Laboratories"), a wholly-owned subsidiary of Mylan Inc and one of the promoters of the Company, proposing a voluntary delisting offer to the public shareholders of the Company in accordance with the Securities and Exchange Board of India (Delisting of Securities) Guidelines, 2003 ("Delisting Guidelines") with a view to acquire the remaining public shareholding of the Company and to deli

Matrix Laboratories Limited has informed the Exchange that the Annual General Meeting of the Company will be convened on September 15, 2008. The Register of Members and Share Transfer Books of the Company will be closed from September 11, 2008 to September 15, 2008 for the purpose of holding the Annual General Meeting.

Matrix Laboratories Limited has informed the Exchange that the Board of Directors at their meeting held on May 23, 2007, considered and approved the following items: (1) To convene and conduct Annual General Meeting of the Company on July 16, 2007.(2) Closure of Register of Members and Share Transfer Books from July 11, 2007 to July 16, 2007 for the purpose of AGM.

DSP Merrill Lynch Limited has submitted to the Exchange a copy of the Corrigendum to the Public Announcement made on August 29,2006, which has been made by DSP Merill Lynch Limited as Manager to the Offer on behalf of MP Laboratories (Mauritius) Ltd. (hereinafter referred to as "Acquirer"), and Mylan Laboratories Inc. (hereinafter referred to as "Mylan" / "Person acting in concert"/"PAC") to the shareholders of Matrix. The original and revised schedule of major activities of the offer is as follows : (1) Date of opening of the offer (a) October 20, 2006 (Original) (b) November 22, 2006 (Revis

Therefore, the Acquirer along with the PAC, is making an offer to public shareholders of Matrix ("Shareholders") to acquire up to 30,831,962 voting equity shares ("Share(s)") of Rs. 2 each, representing in the aggregate 20.0% of the fully diluted voting equity shares capital of Matrix at a price of Rs. 306 (Rupees three hundred six only) per share ("Offer Price"), payable in cash and subject to the terms and conditions mentioned hereinafter ("Offer"). The Acquirer will purchase all the Shares tendered and accepted under this Offer, subject to certain conditions and other terms and conditions s

DSP Merrill Lynch Ltd has informed the Exchange regarding the Public Announcement (the "PA") being issued by DSP Merrill Lynch Limited ("Manager to the Offer"/"DSPML"), on behalf of MP Laboratories (Mauritius) Ltd. (hereinafter referred to as "Acquirer"), and Mylan Laboratories Inc. (hereinafter referred to as "Mylan" / "Persons acting in concert" / "PAC") pursuant to Regulation 10 and 12 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulation, 1997 (the "SEBI(SAST) Regulation"). The Acquirer, a company with limited liability, incorporated und

Matrix Laboratories Limited has informed the Exchange that the BOD's at their meeting held on July 27, 2006, considered and approved the following business: 1) Closure of Register of Members and Share Transfer Books from September 20, 2006 to September 25, 2006 for the purpose of AGM and dividend; 2) To convene and conduct AGM of the Company on September 25, 2006.

Matrix Laboratories Limited has informed the Exchange that the Equity Shares of the Company are delisted from the Hyderabad Stock Exchange w.e.f. December 15, 2005 after complying all the statutory formalities.

Matrix Laboratories Limited has informed the Exchange that the Board of Directors at their meeting held on June 19, 2005, have proposed for Voluntary Delisting from the Hyderabad Stock Exchange Limited, subject to the approval of the shareholders of the Company by way of Special resolution, in the ensuing AGM schedule to be held on August 25, 2005 and other applicable provisions of Securities and Exchange Board of India (Delisting of Securities) Guidelines 2003.

Matrix Laboratories Limited has informed the Exchange that the BOD's at their meeting held on June 01, 2005, considered / approved the following business: 1) Fixed Book closure dates from August 22, 2005 to August 25, 2005 (both days inclusive) for payment of dividend and AGM; 2) To convene and conduct AGM of the Company on August 25, 2005.

Matrix Laboratories Limited has informed the Exchange that the BODs at their meeting held on December 16, 2004, have fixed January 20, 2005 as Record Date for Sub-division of Equity Shares and Bonus Issue. The Board also constituted Compensation Committee for administration and superintendence of ESOP 2004 with the following Directors: 1) Mr. Puneet Bhatia-Chairman, 2) Mr. C. Ramakrishna-Member and 3 )Mr. N. Prasad-Member.

Matrix Laboratories Limited has informed the Exchange that the BOD at their meeting held on October 30, 2004, have approved the following : 1) approval of the notice for convening the AGM of the company on December 16, 2004. 2) fixation of the period for book closure from December 13, 2004 to December 16, 2004 for the purpose of AGM and payment of dividend.

Matrix Laboratories Limited had informed the Exchange that the Hon'ble High Court of Andhra Pradesh has sanctioned the Scheme of Arrangement for Amalgamation amongst Vera Laboratories Limited, Fine Drugs and Chemicals Limited, Medikon Laboratories Limited and Calibre Engineering Private Limited Transferor Companies) with Matrix Laboratories Limited (Transferee Company) vide its order dated October 13, 2004. The Appointed date for merger is January 01, 2004. The Company has further informed that in line with the Scheme of Arrangement for Amalgamation, the BOD's of the Matrix Laboratories Limite